Acrisure

For most retail participants, gaining price exposure to a late-stage private company like Acrisure has historically been a structural impossibility. This section outlines the access advantage the CoinUnited pre-IPO CFD provides, the qualitative valuation story, the structural bull case, and the material risks a trader should weigh before opening a position.

The Access Wedge

They also require identity verification, financial-eligibility documentation, and multi-day onboarding processes.

CoinUnited's pre-IPO CFD removes those barriers. Minimum exposure starts from US$100 and no accreditation requirement applies. Accounts are funded and withdrawn in crypto, bypassing the need for a traditional bank account or standard brokerage paperwork.

One structural clarification is important: this is a CFD, not equity. It provides synthetic price exposure to Acrisure's private-market reference price. It confers no shareholding, voting rights, dividends, or IPO allocation. Traders are taking a position on the price trajectory of the reference valuation, not acquiring a stake in the company.

The Valuation Re-Rating Story

Acrisure's implied equity value has followed a distinct upward trajectory across successive private funding rounds. In 2016, the company carried an enterprise value of approximately $2.9 billion. By May 2022, reported valuations had reached $23 billion.

A 2024 funding round was associated with that same $23 billion mark, and as of May 2025, Reuters reported an implied equity valuation of $32 billion.

This trajectory, from sub-$3 billion to $32 billion over roughly nine years, reflects acquisition volume, a fintech platform build-out, and successive injections of institutional capital from backers including Genstar Capital, Harvest Partners, Blackstone, and ADIA.

Critically, private-market valuations are set at discrete funding events, not through continuous price discovery, so the reference price can lag material changes in the underlying business between rounds.

Structural Bull Case

Insurance distribution is a durable, fee-based business model. Brokers earn commissions and fees on policy placements, generating recurring revenue that is relatively insulated from the underwriting cycle.

Acrisure's roll-up of well over 1,000 agencies concentrates distribution at scale in a sector that remains highly fragmented, which creates both ongoing acquisition opportunity and defensible market position.

The fintech overlay, technology layered across the aggregated agency network, may support a valuation premium above pure-play brokers if it demonstrably improves retention, cross-sell, and operational margins. The calibre of institutional backers, including a sovereign wealth fund and one of the largest alternative-asset managers, signals ongoing private-market confidence in the growth path.

For context on how late-stage private companies are being priced more broadly in 2026, the 2026 Pre-IPO Market Outlook provides relevant sector framing.

Risk Factors

Several risks are specific to this instrument and this asset.

No confirmed IPO timeline. As of October 2026, Acrisure had not announced an IPO filing, listing timetable, SPAC transaction, or direct-listing plan. This creates indefinite holding-period risk: the catalyst that might close the gap between private and public-market pricing has no visible schedule.

Discrete valuation updates. Private-round pricing is episodic. The reference price does not adjust continuously to news flow, meaning a trader's CFD exposure may not reflect interim business developments until a new funding event or external pricing event occurs.

Scheduled trading sessions and weekend gap risk. This instrument trades during scheduled market sessions and is closed at weekends and on market holidays. Price-sensitive news that breaks outside trading hours, including over a weekend, cannot be acted on until the next open, and the reference price may gap materially when trading resumes.

Traders should size positions with this in mind and review open exposure before each session close.

Leverage amplification. The Acrisure pre-IPO CFD is available with up to 100x leverage, subject to product, jurisdiction, and account eligibility. While leverage magnifies potential returns, it equally amplifies losses and raises the risk of liquidation on adverse moves in the reference price. Position sizing relative to available margin should be considered carefully.

Fees. Trading fees on this instrument are tiered by 30-day contract volume and are not zero at the standard tier. The applicable rate at your account level is shown live on the platform and in the fee schedule at coinunited.io/en/account/trading-fees.

Fragmented secondary-market data. Pricing for private Acrisure shares in secondary markets is not centrally verified, which means the reference price carries inherent uncertainty relative to exchange-listed instruments.

Regulatory and macro risks. Insurance brokerage is subject to state-level licensing in the US and equivalent regulatory regimes internationally. A prolonged M&A slowdown or tightening credit conditions could compress acquisition-driven growth. A down-round IPO, where the public listing prices below the last private-round valuation, would directly affect the CFD reference price.

The ACRISURE instrument on CoinUnited is a pre-IPO CFD, a synthetic derivative that provides price exposure to Acrisure's private-market reference price. It is not equity. Opening a position does not confer shareholding, voting rights, dividend entitlement, or any allocation in a future IPO.

The sections below cover instrument mechanics, leverage, position sizing, gap risk, and IPO-event handling in sequence.

Instrument Mechanics

The CFD tracks a reference price derived from Acrisure's private-market valuation signals: disclosed funding-round data and secondary-market transactions where available. Because Acrisure is not exchange-listed, there is no continuous order book.

The reference price updates when new valuation data enters the market, such as a funding round or a reported secondary transaction, rather than tick by tick. This makes the instrument structurally different from a CFD on a listed equity or major cryptocurrency.

CoinUnited accounts are funded and withdrawn in crypto. No traditional bank account is required, and onboarding does not involve the documentation typical of conventional brokerages. The minimum exposure is US$100, and no accreditation status is required to open a position.

Trading sessions for this instrument follow a scheduled calendar and are closed at weekends and on market holidays. Weekend gap risk is therefore a genuine consideration: if material news about Acrisure's valuation emerges over a weekend, the reference price may open meaningfully higher or lower when the market resumes.

Factoring this into position sizing and risk management is part of actively holding an ACRISURE CFD.

Leverage and Exposure Calculations

CoinUnited offers up to 100x leverage on the ACRISURE pre-IPO CFD, subject to product terms, jurisdiction, and account eligibility. Higher leverage materially increases liquidation risk. The table below shows how leverage scales notional exposure and margin requirements across a range of position sizes.

At 100x leverage, a 1% move in the reference price produces a 100% gain or loss on the margin deployed. A 1% adverse move wipes the position entirely at maximum leverage. These figures are hypothetical and illustrative; actual outcomes depend on entry price, applicable fees, and exact contract terms.

Trading fees on CoinUnited are tiered by 30-day contract volume and reach 0.000% only at VIP 9; the standard tier is not free. Review the full fee schedule before opening a position.

Gap Risk and Position Sizing

Because Acrisure's reference price updates on the basis of infrequent private-market events rather than continuous trading, gap risk is structurally higher than for exchange-listed instruments. A new funding round or a secondary-market transaction can reset the reference price materially between updates, with no intermediate price levels at which a stop-loss order could execute.

The instrument's scheduled trading sessions — closed at weekends and on market holidays — create additional windows during which news can accumulate and open with a gap.

Practical implications for position sizing:

• -Size relative to total portfolio risk, not just margin. At high leverage on a thin-discovery instrument, even a modest gap in the reference price can exceed the margin on a single position.
• -Use available stop-loss tools. CoinUnited provides stop-loss functionality; setting stops helps define maximum loss per position, though gap events can cause execution beyond the stop level.
• -Avoid concentrating leverage on a single pre-IPO name. Price discovery for private companies is structurally limited. Diversifying across instruments reduces the impact of a single gap event.
• -Treat the reference price as a snapshot, not a stream. The last reference price may reflect data that is weeks or months old relative to any new private-market transaction.

For context on how pre-IPO instruments are positioned within the broader 2026 private-market landscape, the 2026 Pre-IPO Market Outlook provides relevant sector-level context.

IPO Event Handling

As of October 2026, Acrisure had not announced an IPO filing, public listing timetable, SPAC transaction, or direct-listing plan. If a public listing does occur, CoinUnited's pre-IPO CFD will be subject to the platform's standard position-settlement or conversion mechanics at that time.

Possible outcomes at an IPO event may include settlement at a reference price, conversion to a post-IPO CFD, or position closure. No specific outcome is guaranteed. Traders with open positions at the time of any listing announcement should review CoinUnited's specific product terms for that instrument, as the applicable mechanics will be defined there rather than in general platform documentation.

Monitoring corporate news flow on Acrisure is therefore part of active risk management for anyone holding an open ACRISURE CFD position.